{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:17:38Z","timestamp":1791415058006,"version":"4.3.3"},"reference-count":39,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MOST","award":["101-2314-B-418-012-MY3"],"award-info":[{"award-number":["101-2314-B-418-012-MY3"]}]},{"name":"MOST","award":["104-2314-B-418-008"],"award-info":[{"award-number":["104-2314-B-418-008"]}]},{"name":"MOST","award":["105-2628-B-418-002-MY2"],"award-info":[{"award-number":["105-2628-B-418-002-MY2"]}]},{"name":"MOST","award":["107-2314-B-418-006-MY3"],"award-info":[{"award-number":["107-2314-B-418-006-MY3"]}]},{"name":"National Science and Technology Council","award":["108-2314-B-002-217"],"award-info":[{"award-number":["108-2314-B-002-217"]}]},{"name":"National Science and Technology Council","award":["109-2314-B-002-108"],"award-info":[{"award-number":["109-2314-B-002-108"]}]},{"name":"National Science and Technology Council","award":["110-2314-B-002-146"],"award-info":[{"award-number":["110-2314-B-002-146"]}]},{"name":"National Science and Technology Council","award":["114-2314-B-002-197-MY3"],"award-info":[{"award-number":["114-2314-B-002-197-MY3"]}]},{"name":"National Taiwan University Cancer Center","award":["NTUCCS-115-33"],"award-info":[{"award-number":["NTUCCS-115-33"]}]},{"award":["NTUCCS-115-33"],"award-info":[{"award-number":["NTUCCS-115-33"]}],"id":[{"id":"https:\/\/ror.org\/05bqach95","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"crossref","award":["101-2314-B-418-012-MY3"],"award-info":[{"award-number":["101-2314-B-418-012-MY3"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"crossref","award":["104-2314-B-418-008"],"award-info":[{"award-number":["104-2314-B-418-008"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"crossref","award":["105-2628-B-418-002-MY2"],"award-info":[{"award-number":["105-2628-B-418-002-MY2"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"crossref","award":["107-2314-B-418-006-MY3"],"award-info":[{"award-number":["107-2314-B-418-006-MY3"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"crossref"}]},{"award":["101-2314-B-418-012-MY3"],"award-info":[{"award-number":["101-2314-B-418-012-MY3"]}],"id":[{"id":"https:\/\/ror.org\/019tq3436","id-type":"ROR","asserted-by":"publisher"}]},{"award":["104-2314-B-418-008"],"award-info":[{"award-number":["104-2314-B-418-008"]}],"id":[{"id":"https:\/\/ror.org\/019tq3436","id-type":"ROR","asserted-by":"publisher"}]},{"award":["105-2628-B-418-002-MY2"],"award-info":[{"award-number":["105-2628-B-418-002-MY2"]}],"id":[{"id":"https:\/\/ror.org\/019tq3436","id-type":"ROR","asserted-by":"publisher"}]},{"award":["107-2314-B-418-006-MY3"],"award-info":[{"award-number":["107-2314-B-418-006-MY3"]}],"id":[{"id":"https:\/\/ror.org\/019tq3436","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: To evaluate whether global myocardial glucose metabolism and its regional heterogeneity, quantified using dynamic 18F-fluorodeoxyglucose positron emission tomography (FDG PET), are associated with cardiovascular outcomes in patients with ischemic cardiomyopathy. Methods: The analytic cohort included 120 patients with suspected ischemic cardiomyopathy who underwent thallium-201 perfusion single photon emission tomography and dynamic FDG PET. Global myocardial metabolic rate of glucose (MRGlu) and coefficient of variation in FDG uptake were calculated from scar-excluded myocardium. Major adverse cardiac events (MACEs) were assessed over a median follow-up of 2.5 years. Public myocardial gene-expression datasets (GSE116250 and GSE135055) were analyzed to explore glucose metabolism-related transcriptional patterns relevant to the imaging findings. Results: Fifty-one patients (42.5%) experienced MACEs. Lower global MRGlu was independently associated with improved MACE-free survival (hazard ratio 0.48, 95% confidence interval 0.27\u20130.87). Among patients with low global MRGlu, a high coefficient of variation predicted favorable outcomes (hazard ratio 0.35, 95% confidence interval 0.18\u20130.68), indicating beneficial metabolic heterogeneity. Analysis of external gene-expression data demonstrated consistent downregulation of glucose-handling genes in end-stage heart failure across ischemic and dilated etiologies. A higher expression of SLC2A1, HK1, IRS1, and PKM was associated with faster progression to transplantation. Conclusions: In ischemic cardiomyopathy, dynamic FDG PET-derived quantification of myocardial glucose metabolism provides prognostic information beyond traditional viability assessment. Low global metabolism combined with preserved metabolic heterogeneity helps identify patients with favorable clinical outcomes.<\/jats:p>","DOI":"10.3390\/diagnostics16142237","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:32:08Z","timestamp":1784514728000},"page":"2237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of Dynamic FDG PET-Derived Myocardial Glucose Metabolism in Ischemic Cardiomyopathy with Supportive External Gene-Expression Analysis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-9621","authenticated-orcid":false,"given":"Kuan-Yin","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, National Taiwan University Cancer Center and College of Medicine, National Taiwan University, Taipei 100233, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Lin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Cheng","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ming","family":"Tu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chien","family":"Shiau","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ming","family":"Chiu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Surgery, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0143-5642","authenticated-orcid":false,"given":"Wen-Pin","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei 100233, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-1166","authenticated-orcid":false,"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"},{"name":"Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220216, Taiwan"},{"name":"School of Medicine, National Yang Ming Chao Tung University, Taipei 112304, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: A report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e012673","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jacc.2004.12.057","article-title":"Infarct morphology identifies patients with substrate for sustained ventricular tachycardia","volume":"45","author":"Bello","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e000053","DOI":"10.1161\/HCI.0000000000000053","article-title":"State of the art: Imaging for myocardial viability: A scientific statement from the American Heart Association","volume":"13","author":"Garcia","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e004331","DOI":"10.1161\/CIRCIMAGING.115.004331","article-title":"Long-term follow-up of outcomes with F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease","volume":"9","author":"Shukla","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"154862","DOI":"10.1016\/j.metabol.2021.154862","article-title":"Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study","volume":"123","author":"Luong","year":"2021","journal-title":"Metabolism"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCIMAGING.109.853291","article-title":"In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome","volume":"2","author":"Ha","year":"2009","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12350-018-1395-4","article-title":"Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy","volume":"27","author":"Ko","year":"2020","journal-title":"J. Nucl. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00259-019-04471-9","article-title":"Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction","volume":"46","author":"Tsai","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.nuclcard.2006.08.009","article-title":"Positron emission tomography myocardial perfusion and glucose metabolism imaging","volume":"13","author":"Machac","year":"2006","journal-title":"J. Nucl. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(99)00010-8","article-title":"Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction","volume":"33","author":"Campisi","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"J. Am. Coll. Cardiol. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hua, X., Wang, Y.Y., Jia, P., Xiong, Q., Hu, Y., Chang, Y., Lai, S., Xu, Y., Zhao, Z., and Song, J. (2020). Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression. BMC Med., 18.","DOI":"10.1186\/s12916-019-1469-4"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11897-016-0289-5","article-title":"Metabolic dysfunction in heart failure: Diagnostic, prognostic, and pathophysiologic insights from metabolomic profiling","volume":"13","author":"Hunter","year":"2016","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12265-023-10412-7","article-title":"From energy metabolic change to precision therapy: A holistic view of energy metabolism in heart failure","volume":"17","author":"Wen","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2021.02.057","article-title":"Therapeutic manipulation of myocardial metabolism","volume":"77","author":"Honka","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95","author":"Ingwall","year":"2004","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014An engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","article-title":"Insulin signalling in the heart","volume":"79","author":"Bertrand","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1085\/jgp.201310968","article-title":"Hexokinase-mitochondrial interactions regulate glucose metabolism differentially in adult and neonatal cardiac myocytes","volume":"142","author":"Calmettes","year":"2013","journal-title":"J. Gen. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/bph.12363","article-title":"Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart","volume":"171","author":"Nederlof","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.2337\/db13-0095","article-title":"Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38\u03b1 MAPK during insulin resistance","volume":"62","author":"Qi","year":"2013","journal-title":"Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Garc\u00eda, M., Pujol, A., Ruzo, A., Riu, E., Ruberte, J., Arb\u00f3s, A., Seraf\u00edn, A., Albella, B., Fel\u00edu, J.E., and Bosch, F. (2009). Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000615"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000001568","article-title":"Pyruvate kinase M2: A potential regulator of cardiac injury through glycolytic and non-glycolytic pathways","volume":"84","author":"Zeng","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.111.255505","article-title":"AMP-activated protein kinase regulation and biological actions in the heart","volume":"111","author":"Zaha","year":"2012","journal-title":"Circ. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.98.20.2180","article-title":"Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo","volume":"98","author":"Russell","year":"1998","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI7605","article-title":"Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart","volume":"104","author":"Abel","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: Implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Karwi, Q.G., Uddin, G.M., Ho, K.L., and Lopaschuk, G.D. (2018). Loss of metabolic flexibility in the failing heart. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00068"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvt216","article-title":"Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation","volume":"101","author":"Masoud","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41574-025-01092-1","article-title":"The enduring relevance of the Randle cycle","volume":"21","author":"Challa","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-023-01018-w","article-title":"The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches","volume":"118","author":"Chen","year":"2023","journal-title":"Basic Res. Cardiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:15:06Z","timestamp":1784520906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":39,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16142237"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16142237","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}